IGF1 and Hyperglycemia: The underlying pathophysiological mechanisms of T2DM and CRC include hyperglycaemia, insulin-IGF-1 axis signalling, hyperinsulinaemia, inflammation caused by adipose tissue dysfunction, gastrointestinal motility disorders, and immune damage.